Article

DSAEK results in better visual acuity values compared with DLEK and DSEK

Evaluation of the visual, topographic, and astigmatic results of small-incision deep lamellar endothelial keratoplasty (DLEK), Descemet's stripping endothelial keratoplasty (DSEK), and Descemet's stripping automated endothelial keratoplasty (DSAEK) indicated that 6 months postoperatively there are visual acuity differences, with DSAEK providing high visual acuity levels, reported Neda Shamie, MD, Devers Eye Institute, Portland, OR.

Evaluation of the visual, topographic, and astigmatic results of small-incision deep lamellar endothelial keratoplasty (DLEK), Descemet's stripping endothelial keratoplasty (DSEK), and Descemet's stripping automated endothelial keratoplasty (DSAEK) indicated that 6 months postoperatively there are visual acuity differences, with DSAEK providing high visual acuity levels, reported Neda Shamie, MD, Devers Eye Institute, Portland, OR.

"With the rapid evolution in the procedures, the burden is on us to show that this evolution is in fact a move toward improvement," Dr. Shamie said. She and her colleagues conducted a prospective comparative case series of DLEK (n = 205 cases), DSAEK (n = 80 cases), and DSEK (n = 26 cases) performed by three surgeons.

Dr. Shamie reported that the mean astigmatic and mean keratometric values were essentially the same in the three groups, with no changes from the preoperative values.

"The visual acuity values at 6 months postoperatively differed among the groups," she reported. The mean DLEK visual acuity was 20/43 (range, 20/20 to 20/100) in 158 cases; the mean DSEK visual acuity was 20/50 (range, 20/20 to 20/63) in 20 cases; and the mean DSAEK visual acuity was 20/30 (range, 20/20 to 20/50) in 63 cases.

There was no statistical difference between the visual acuity levels of DLEK and DSEK after 6 months. There was a significant difference between DLEK and DSAEK (p p

Ninety-four percent of the DSAEK eyes reached a visual acuity of 20/40 at 6 months compared with only 59% of the DLEK eyes and 50% of the DSEK eyes. The respective percents for 20/20 or better vision at 6 months were 13%, 6%, and 1%.

"What is the reason for the differences in visual acuity? Patient variables, preexisting changes in residual stroma, and the power of the study are important qualities to think about. However, the interface quality is likely the main variable," Dr. Shamie concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.